Marek Fischer

Overview

Best Publications

• Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

  Hansruedi Büeler;Marek Fischer;Yolande Lang;Yolande Lang;Horst Bluethmann;Horst Bluethmann

  2128
  Citations

• Normal host prion protein necessary for scrapie-induced neurotoxicity

  Sebastian Brandner;Stefan Isenmann;Alex Raeber;Marek Fischer

  992
  Citations

• Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

  Alexandra Trkola;Herbert Kuster;Peter Rusert;Beda Joos

  672
  Citations

• HIV rebounds from latently infected cells, rather than from continuing low-level replication.

  Beda Joos;Marek Fischer;Herbert Kuster;Satish K. Pillai

  360
  Citations

• Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system

  Sebastian Brandner;Alex Raeber;Andreas Sailer;Andreas Sailer;Thomas Blättler

  334
  Citations

• Differences in HIV Burden and Immune Activation within the Gut of HIV-Positive Patients Receiving Suppressive Antiretroviral Therapy

  Steven A. Yukl;Steven A. Yukl;Sara Gianella;Sara Gianella;Elizabeth Sinclair;Lorrie Epling

  334
  Citations

• Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence

  M. C. Strain;H. F. Günthard;D. V. Havlir;C. C. Ignacio

  309
  Citations

• Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

  Annette Oxenius;David A. Price;Huldrych F. Günthard;Sara J. Dawson

  283
  Citations

• Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

  Steven Yukl;Amandeep Shergill;Kenneth McQuaid;Sara Gianella

  280
  Citations

• A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection

  Milos Opravil;Bernard Hirschel;Adriano Lazzarin;Hansjakob Furrer

  189
  Citations

• Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions

  Karin J. Metzner;Karin J. Metzner;Sebastian Bonhoeffer;Marek Fischer;Rose Karanicolas

  177
  Citations

• RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement

  Branka Roscic-Mrkic;Marek Fischer;Christine Leemann;Amapola Manrique

  167
  Citations

• Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

  Michael Huber;Marek Fischer;Benjamin Misselwitz;Amapola Manrique

  142
  Citations

• Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication

  Alex J. Raeber;Andreas Sailer;Ivan Hegyi;Michael A. Klein

  135
  Citations

• In Vivo and In Vitro Escape from Neutralizing Antibodies 2G12, 2F5, and 4E10

  Amapola Manrique;Peter Rusert;Beda Joos;Marek Fischer

  121
  Citations

• Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection

  Adrian Schmid;Sara Gianella;Viktor von Wyl;Karin J. Metzner

  116
  Citations

• Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.

  Peter Rusert;Marek Fischer;Beda Joos;Christine Leemann

  114
  Citations

• Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.

  Sara Gianella;Viktor von Wyl;Marek Fischer;Barbara Niederoest

  111
  Citations

• HIV RNA in plasma rebounds within days during structured treatment interruptions.

  Marek Fischer;Roland Hafner;Christine Schneider;Alexandra Trkola

  111
  Citations

• Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.

  Peter Rusert;Herbert Kuster;Beda Joos;Benjamin Misselwitz

  108
  Citations

• Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes

  Philipp Kaiser;Beda Joos;Barbara Niederöst;Rainer Weber

  98
  Citations